EUVIMEDEUVIMED entdecken
Leserbrief

Visceral leishmaniasis associated with ixekizumab therapy presenting as hemophagocytic lymphohistiocytosis

Ángela García-Oro, Amparo Puerta-García, Javier Solera

Medicina Clínica · 2026-10 · 107683

DOI: 10.1016/j.medcli.2026.107683 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Medicina Clínica, 2026-10. Verfasst von Ángela García-Oro und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Hospital General de Villarrobledo, Albacete, Spain. Electronic address: angelagarciaoro@hotmail.com. Die Arbeit nennt 5 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Department of Internal Medicine, Hospital General de Villarrobledo, Albacete, Spain. Electronic address: angelagarciaoro@hotmail.com.
  • Department of Internal Medicine, Hospital Quironsalud Albacete, Albacete, Spain.
  • Honorary Professor, Faculty of Medicine, University of Castilla-La Mancha, Albacete, Spain.

Zitieren

APA

García-Oro, Á., Puerta-García, A., & Solera, J. (2026). Visceral leishmaniasis associated with ixekizumab therapy presenting as hemophagocytic lymphohistiocytosis. Medicina Clínica, 107683. https://doi.org/10.1016/j.medcli.2026.107683

Vancouver

García-Oro Á, Puerta-García A, Solera J. Visceral leishmaniasis associated with ixekizumab therapy presenting as hemophagocytic lymphohistiocytosis. Medicina Clínica. 2026:107683. doi:10.1016/j.medcli.2026.107683

BibTeX
@article{GarcaOro2026,
  author = {García-Oro, Ángela and Puerta-García, Amparo and Solera, Javier},
  title = {Visceral leishmaniasis associated with ixekizumab therapy presenting as hemophagocytic lymphohistiocytosis},
  journal = {Medicina Clínica},
  year = {2026},
  pages = {107683},
  doi = {10.1016/j.medcli.2026.107683}
}
Kostenlos starten →